- Rakshit Choudhary promoted to co-CEO, partnering with Founder and CEO Jean-Yves Sireau
- Deriv refreshes its leadership model as it gets set to celebrate its 25th anniversary
Rakshit Choudhary, co-CEO of Deriv
CYBERJAYA, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- In a significant move for the online trading company, as it approaches its 25th anniversary, Deriv has announced the promotion of Rakshit Choudhary from Chief Operating Officer (COO) to co-Chief Executive Officer (co-CEO). The co-CEO model will capitalise on the different strengths and diverse perspectives of both leaders.
Choosing the co-model is not just a strategic move for Deriv. It lets the organisation incorporate diverse viewpoints and teamwork into critical decision-making to keep the business agile. This double leadership framework also creates an environment where reciprocal respect and shared accountability are standard practices and balances individual autonomy with a collective vision.
Jean-Yves Sireau, Founder and co-CEO of Deriv, said: “Rakshit is a great leader with a deep understanding of Deriv’s business, so his move to co-CEO is a natural step forward for us. It is like the synergy you see in pair programming—improved decision-making and better alignment of goals.
“Deriv turning 25 is a moment for reflection. Refreshing our leadership model makes us well-positioned to take on the next phase of Deriv’s business, which is focused on expanding globally and engaging more deeply with diverse markets. This dual leadership approach helps keep Deriv innovative and committed to excellent customer service and strong partnerships.”
Choudhary, who holds a Master’s degree from Georgia Institute of Technology, joined Deriv in 2009 as a Quantitative Analyst and then Head of Quantitative Development & Research. His next role at Deriv was Head of Product Development before his promotion to COO in 2018.
Rakshit Choudhary shared his thoughts on his new role: “I have been lucky to be part of Deriv’s incredible growth and evolution for the last 14 years, witnessing firsthand its mission to make trading accessible to anyone, anywhere. At the centre of this is a focus on staying innovative, secure, and accessible. I look forward to continuing to grow Deriv’s business globally alongside Jean-Yves, as we take the company into another successful 25 years.”
Deriv has also transitioned to a co-CFO model with Jennice Lourdsamy, previously Head of Accounts and Payments taking a double leadership role as co-CFO alongside Louise Wolf, the current CFO. The co-leadership mindset does not end at the C-level. It is practised across Deriv at all levels, in line with the company’s values of integrity, competence, customer focus, and teamwork.
Deriv remains committed to its principles of leadership excellence, marked by clear vision, result-oriented approaches, continuous learning, and a bias for action. These principles are embedded in daily operations and are critical to achieving Deriv’s mission of making advanced trading solutions accessible worldwide.
About Deriv
For 25 years, Deriv has been committed to making online trading accessible to anyone, anywhere. Trusted by over 2.5 million traders worldwide, the company offers an expansive range of trade types and boasts over 200 assets across popular markets on its award-winning, intuitive trading platforms. With a workforce of more than 1,400 people globally, Deriv has cultivated an environment that celebrates achievements, encourages professional growth, and fosters talent development, which is reflected in its Platinum accreditation by Investors in People.
PRESS CONTACT
pr@deriv.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2a2adfa8-5309-4a67-88cf-69d000020b5a
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17